Brief: S2medical Positive Result For Epiprotect In New Independent Study
July 1 (Reuters) - S2Medical AB (publ) S2ME.ST :
* POSITIVE RESULT FOR EPIPROTECT IN NEW INDEPENDENT STUDY
* RESULTS OF STUDY SHOWED, AMONG OTHER THINGS, THAT USE OF
EPIPROTECT RESULTED IN LOWER PAIN, LESS ANXIETY FOR THE
PATIENTS' PARENTS AND LESS SCARS COMPARED TO NON-ATTACHING GAUZE
Source text for Eikon: ID:nWkr9CyHfp
Further company coverage: S2ME.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on S2Medical AB (publ)
See all newsBrief: Eyracure Company Part-owned By S2Medical Files For Bankruptcy
Brief: S2Medical Plans Rights Issue To Raise SEK 2.9 Mln
Brief: S2medical H2 Net Sales At SEK 7.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement In UAE
Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries